廣(guang)(guang)東(dong)(dong)一(yi)(yi)(yi)方制(zhi)藥(yao)(yao)(yao)有(you)限公(gong)司(si)隸屬于國藥(yao)(yao)(yao)集團中(zhong)(zhong)(zhong)國中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)控股有(you)限公(gong)司(si),1992年由廣(guang)(guang)東(dong)(dong)省(sheng)中(zhong)(zhong)(zhong)醫(yi)藥(yao)(yao)(yao)工(gong)程技術研(yan)(yan)究(jiu)院(yuan)創辦,是國家(jia)“中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)飲片(pian)劑型改革生(sheng)產(chan)基地(di)”和(he)國家(jia)“中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)配(pei)方顆(ke)粒試點生(sheng)產(chan)企業(ye)”,一(yi)(yi)(yi)方制(zhi)藥(yao)(yao)(yao)依托研(yan)(yan)究(jiu)院(yuan)和(he)廣(guang)(guang)東(dong)(dong)省(sheng)第二中(zhong)(zhong)(zhong)醫(yi)院(yuan)的強(qiang)大科(ke)研(yan)(yan)和(he)臨(lin)(lin)床支持,研(yan)(yan)究(jiu)生(sheng)產(chan)了700余(yu)味產(chan)品(pin),建(jian)立了中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)配(pei)方顆(ke)粒特征圖譜質量控制(zhi)標(biao)準(zhun),開展(zhan)了中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)譜效學研(yan)(yan)究(jiu)、等量性(xing)與(yu)(yu)等效性(xing)研(yan)(yan)究(jiu)等科(ke)研(yan)(yan)工(gong)作,與(yu)(yu)研(yan)(yan)究(jiu)院(yuan)共同承擔完成省(sheng)、部級科(ke)研(yan)(yan)課題近40項。目前擁有(you)佛山和(he)順一(yi)(yi)(yi)方、佛山里水一(yi)(yi)(yi)方、甘肅隴(long)西(xi)一(yi)(yi)(yi)方、山東(dong)(dong)臨(lin)(lin)沂一(yi)(yi)(yi)方、浙江磐安一(yi)(yi)(yi)方、湖南(nan)常(chang)德一(yi)(yi)(yi)方、江西(xi)南(nan)昌一(yi)(yi)(yi)方、陜西(xi)一(yi)(yi)(yi)方、廣(guang)(guang)西(xi)桂林一(yi)(yi)(yi)方以及甘肅隴(long)中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)業(ye)、山東(dong)(dong)中(zhong)(zhong)(zhong)平(ping)藥(yao)(yao)(yao)業(ye)等十一(yi)(yi)(yi)大生(sheng)產(chan)基地(di),100余(yu)個(ge)常(chang)用品(pin)種(zhong)的藥(yao)(yao)(yao)材基地(di)。
一(yi)方制藥(yao)于1999年(nian)通過澳(ao)大(da)利亞(ya)TGA的GMP認(ren)(ren)證(zheng),2001年(nian)研(yan)制出中藥(yao)配方顆粒(li)智能調配系統,2018年(nian)通過國(guo)(guo)家CNAS實驗室認(ren)(ren)證(zheng),2019年(nian)被認(ren)(ren)定(ding)(ding)為國(guo)(guo)家企業技術中心,是中藥(yao)配方顆粒(li)國(guo)(guo)家標(biao)準參與制定(ding)(ding)單位之一(yi)。產品已覆蓋(gai)全國(guo)(guo)所有(you)省(sheng)、市、區和歐洲、北美洲、澳(ao)洲、東南亞(ya)等六十余個國(guo)(guo)家和地區。